Ad is loading...
PHSTX
Price
$60.49
Change
-$1.24 (-2.01%)
Updated
Nov 15 closing price
VGHCX
Price
$204.50
Change
-$5.96 (-2.83%)
Updated
Nov 15 closing price
Ad is loading...

PHSTX vs VGHCX

Header iconPHSTX vs VGHCX Comparison
Open Charts PHSTX vs VGHCXBanner chart's image
Putnam Global Health Care A
Price$60.49
Change-$1.24 (-2.01%)
VolumeN/A
CapitalizationN/A
Vanguard Health Care I
Price$204.50
Change-$5.96 (-2.83%)
VolumeN/A
CapitalizationN/A
PHSTX vs VGHCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PHSTX vs. VGHCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHSTX is a StrongSell and VGHCX is a Sell.

FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 45.7B vs. PHSTX (1.69B). VGHCX pays higher dividends than PHSTX: VGHCX (0.79) vs PHSTX (0.15). PHSTX was incepted earlier than VGHCX: PHSTX (43 years) vs VGHCX (41 years). PHSTX is a more actively managed with annual turnover of: 41.00 vs. VGHCX (16.00). PHSTX has a lower initial minimum investment than VGHCX: PHSTX (0) vs VGHCX (3000). PHSTX annual gain was more profitable for investors over the last year : 6.89 vs. VGHCX (1.65). PHSTX return over 5 years is better than : 12.59 vs. VGHCX (-2.73).
PHSTXVGHCXPHSTX / VGHCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence43 years41 years-
Gain YTD4.781-2.205-217%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.69B45.7B4%
Annual Yield % from dividends0.150.7920%
Returns for 1 year6.891.65419%
Returns for 3 years-11.68-13.8584%
Returns for 5 years12.59-2.73-462%
Returns for 10 years-13.62-9.94137%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UDR44.31-0.24
-0.54%
UDR
EXTO3.91-0.02
-0.57%
Almacenes Exito SA
OI12.97-0.17
-1.29%
O-I Glass
VIRX0.15-0.01
-4.37%
Viracta Therapeutics
PEPG4.12-0.37
-8.24%
PepGen